Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial.

[1]  A. Camm,et al.  Beta blockers and the failing heart: is it time for a U-turn? , 1993, British heart journal.

[2]  K. Swedberg,et al.  Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy. , 1980, British heart journal.

[3]  E. Braunwald,et al.  Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". , 1986, Journal of the American College of Cardiology.

[4]  Eric J. Eichhorn.  Effects of bucindolol in heart failure. , 1993, The American journal of cardiology.

[5]  K Caidahl,et al.  Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. , 1989, Circulation.

[6]  S. Rahimtoola,et al.  The hibernating myocardium. , 1989, American heart journal.

[7]  E. Varnauskas,et al.  Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. , 1975, British heart journal.

[8]  D. Renlund,et al.  Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. , 1990, The American journal of medicine.

[9]  D. Renlund,et al.  beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy. , 1993, The American journal of cardiology.

[10]  W. Grossman,et al.  Are beta-adrenergic-blocking drugs useful in the treatment of dilated cardiomyopathy? , 1985, Circulation.

[11]  P. Held.  Effects of beta blockers on ventricular dysfunction after myocardial infarction: tolerability and survival effects. , 1993, The American journal of cardiology.

[12]  G. Breithardt,et al.  IXth European Congress of Cardiology, Düsseldorf, 8–12 July 1984. Final Report of the Organizing Committee , 1985 .

[13]  Beta-blockers in congestive cardiomyopathy. Conceptual advance or contraindication? , 1986, The American journal of medicine.

[14]  D. Renlund,et al.  Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy. , 1991, Journal of the American College of Cardiology.

[15]  J. Anderson,et al.  A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy. , 1985, The American journal of cardiology.

[16]  D. Renlund,et al.  Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. , 1991, Circulation.

[17]  M. Bristow.  Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents. , 1993, The American journal of cardiology.

[18]  J. V. Nixon,et al.  Reversible segmental left ventricular dysfunction after coronary angioplasty. , 1990, Circulation.

[19]  T. Hedner,et al.  Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. , 1991, Journal of the American College of Cardiology.

[20]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[21]  S. Paridon,et al.  Abnormal Norepinephrine Response to Maximal Exercise in Hypertensive Coarctectomy Patients , 1990 .

[22]  K. Swedberg,et al.  PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE , 1979, The Lancet.

[23]  Eric J. Eichhorn.  The paradox of β-adrenergic blockade for the management of congestive heart failure , 1992 .

[24]  A. Katz.  Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. , 1990, The New England journal of medicine.

[25]  M. Bristow,et al.  Rationale for beta-adrenergic blocking drugs in cardiomyopathy. , 1985, The American journal of cardiology.

[26]  J. Peuler,et al.  Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. , 1977, Life sciences.

[27]  J. Fleiss,et al.  Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure. The Multicenter Diltiazem Post-Infarction Research Group. , 1990, Journal of the American College of Cardiology.

[28]  J. Cohn,et al.  Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. , 1987, American heart journal.

[29]  K. Swedberg,et al.  Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. , 1980, British heart journal.

[30]  K. Iwakura,et al.  Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint. , 1993, Journal of the American College of Cardiology.

[31]  P. Lavori,et al.  Designs for experiments--parallel comparisons of treatment. , 1983, The New England journal of medicine.

[32]  T C Chalmers,et al.  Cumulative meta-analysis of therapeutic trials for myocardial infarction. , 1992, The New England journal of medicine.

[33]  M. Packer,et al.  Pathophysiological mechanisms underlying the effects of beta-adrenergic agonists and antagonists on functional capacity and survival in chronic heart failure. , 1990, Circulation.

[34]  D. Goldstein,et al.  Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. , 1987, The New England journal of medicine.

[35]  B. Parsons,et al.  Adrenergic Effects on the Biology of the Adult Mammalian Cardiocyte , 1992, Circulation.

[36]  H. Valantine,et al.  Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. , 1989, Circulation.

[37]  R. Gunnar,et al.  Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. , 1985, Circulation.

[38]  R. Byington,et al.  Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. , 1986, Circulation.

[39]  M. Jessup.  Beta-adrenergic blockade in congestive heart failure: answering the old questions. , 1991, Journal of the American College of Cardiology.

[40]  P. Broadhurst,et al.  Value of carvedilol in congestive heart failure secondary to coronary artery disease. , 1990, The American journal of cardiology.